¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ - µ¿¹° À¯Çüº°, »ùÇà À¯Çüº°, °Ë»ç À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Pet DNA Testing Market Size, Share & Trends Analysis Report By Animal Type, By Sample Type, By Test Type, By End-user, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå
:
1701351
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 150 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå ±Ô¸ð´Â 2025-2030³â 10.16%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ Àü¸ÁÀ̸ç, 2030³â±îÁö 7¾ï 1,851¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.
¾÷°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¼ÒºñÀÚ À¯ÀüüÇÐ Áõ°¡, ³ôÀº ¹Ý·Áµ¿¹° ÁöÃâ°ú ¹Ý·Áµ¿¹°ÀÇ Àΰ£È, ¹Ý·Áµ¿¹° DNA °Ë»ç Á¦Ç°ÀÇ ÀÎÁöµµ Çâ»ó°ú ÆÇ¸Å, ¿¬±¸ °³¹ß ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ÃÖ±Ù ¹Ý·Áµ¿¹° »çÀ°·üÀÌ Å©°Ô »ó½ÂÇϰí Àֱ⠶§¹®¿¡ °¡Á·Àº ¹Ý·Áµ¿¹°À» À§ÇØ ½Ã°£°ú µ·À» ¾²°Ô µÇ¾ú½À´Ï´Ù. ¹Ì±¹ ¹Ý·Áµ¿¹°¿ëǰÇùȸ(APPA)¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¹Ý·Áµ¿¹° »ê¾÷ ÁöÃâÀº 2020³â 1,036¾ï ´Þ·¯¿¡¼ 2021³â 1,236¾ï ´Þ·¯¿¡ ´ÞÇØ 19% Áõ°¡Çß½À´Ï´Ù.
COVID-19ÀÇ ´ëÀ¯Çà¿¡ ÀÇÇØ ¹Ý·Áµ¿¹° »ê¾÷Àº »õ·Î¿î µ¿ÇâÀ» ³»¼¼¿ì¸ç Å©°Ô ¼ºÀåÇß½À´Ï´Ù. Ư±âÇÒ ¸¸ÇÑ µ¿ÇâÀ¸·Î´Â °³ ¹× °í¾çÀÌ »çÀ° ¸¶¸´¼öÀÇ ±Þ°ÝÇÑ Áõ°¡, ÁÖÀÎÀÌ Áý¿¡¼ º¸³»´Â ½Ã°£ÀÌ ±ä ¹Ý·Áµ¿¹°ÀÇ ÈÞ¸Ó´ÏÁ¦ÀÌ¼Ç °æÇâ °íÁ¶, ¹Ý·Áµ¿¹°ÀÇ Áúº´À̳ª ÇൿÀÇ º¯È¿¡ °üÇÑ »ç¶÷µéÀÇ ÀÇ½Ä °íÁ¶, ÀüÀÚ»ó°Å·¡ Ç÷§ÆûÀÇ ¼ºÀå µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡±¸ ¼öÀÔ Áõ°¡, °æÁ¦ »óȲ º¯È, ¿ø°ÝÁö ±Ù¹« µîµµ ÆÒµ¥¹Í ½Ã±â¿¡ »õ·Î¿î ¹Ý·Áµ¿¹° »çÀ°À» Áõ°¡½ÃŲ °·ÂÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. DNA °Ë»ç´Â ÁÖÀÎÀÌ ¹Ý·Áµ¿¹°ÀÇ ¹Ì·¡¸¦ ´ëºñÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÔÀ¸·Î½á ¹Ý·Áµ¿¹°¿¡°Ô ¸î °¡Áö ÀáÀçÀû ÀÌÀÍÀ» º¸¿©ÁÝ´Ï´Ù.
ƯÁ¤ À¯Àü¼º ÁúȯÀ» »çÀü¿¡ ¾Ë¸é ÁÖÀÎÀº Àû½Ã¿¡ Ä¡·á¸¦ ½ÃÀÛÇÒ ¼ö ÀÖÀ¸¸ç, ³ªÁß¿¡ °í¾×ÀÇ Åõ¾àÀ̳ª Áø´Ü ºñ¿ëÀ» ȸÇÇÇÒ ¼ö ÀÖÀ» °¡´É¼ºµµ ÀÖ½À´Ï´Ù. ¿äÁò ¼¼´ë´Â ¼Ò¼È ¹Ìµð¾î¿¡ Àû±ØÀûÀ̰í, »õ·Î¿î ¹Ý·Áµ¿¹°ÀÇ µ¿Çâ¿¡ ºü¸£°Ô ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡, ¹Ý·Áµ¿¹°ÀÇ ÁÖÀÎ »çÀÌ¿¡¼´Â, ¹Ý·Áµ¿¹° ǰÁ¾ °Ë»ç Á¦Ç°, ±× »ç¿ëÀÇ ¿ëÀ̼º, ±× ³ÐÀº ¿ëµµ¿¡ °üÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. »ç¶÷µéÀº ´Ù¾çÇÑ µ¿¹° ¿ëǰ¿¡ ¸¹Àº ÁöÃâÀ» Çϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ ³ªÀÌ, °ßÁ¾ ±¸¼º, Á¶»ó°úÀÇ °ü°è µîÀ» ÀÌÇØÇÏ´Â µ¥ °ü½ÉÀÌ ¸¹°í, ÁÖÀÎÀº ¹Ý·Áµ¿¹°ÀÇ Çൿ ÆÐÅÏÀ» ÃßÃøÇϰí ÇÊ¿äÇÑ ÈÆÀ°À» ½ÃÀÛÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¹Ì±¹¿¡¼´Â ƯÁ¤ ¾Ö¿Ïµ¿¹° ǰÁ¾ Ä«Å×°í¸®¿¡ ´ëÇÑ »ç¶÷µéÀÇ °ü½ÉÀÌ ³ô¾ÆÁö°í Àֱ⠶§¹®¿¡ Àü¹® ºê¸®´õµé »çÀÌ¿¡¼ ǰÁ¾ °Ë»ç¿Í ±× Á¦Ç°¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
¹ø½Ä ÀýÂ÷ Àü¿¡ ¹Ý·Áµ¿¹°ÀÇ DNA °Ë»ç¿Í À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµÀ» »ç¿ëÇÏ¸é ºê¸®´õ´Â Áúº´ÀÇ À§ÇèÀÌ ³ôÀº °¾ÆÁö¸¦ »ý»êÇÏ´Â °ÍÀ» ¹æÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±àÁ¤ÀûÀÎ ¿äÀÎµé ´öºÐ¿¡ ¹Ý·Áµ¿¹° DNA °Ë»ç Á¦Ç°ÀÇ ÀÎÁöµµ¿Í ¸ÅÃâ¾×Àº Àå±âÀûÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. À¯ÀüüÇÐ ºÐ¾ß°¡ ¼öÀǾ÷°è¿¡¼ Áøº¸ÇÔ¿¡ µû¶ó ¹Ý·Áµ¿¹° À¯ÀüÀÚ °Ë»ç ŰƮ´Â º¸´Ù ÀϹÝÀûÀ¸·Î µÇ°í ÀÖ½À´Ï´Ù. °¢»ç´Â 15³â ÀÌ»ó ÀüºÎÅÍ, ºê¸®´õ, ÁÖÀÎ, ¼öÀÇ»ç Àü¿ëÀ¸·Î °¡Á¤¿¡¼ ÇÒ ¼ö ÀÖ´Â °³¿Í °í¾çÀÌÀÇ DNA °Ë»ç ÀÚ¿øÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. 2009³â ¸¶½ºÆêÄɾ Á÷Á¢ ¼ÒºñÀÚ¿¡°Ô À¯ÀüÀÚ °Ë»ç Á¦Ç°À» µµÀÔÇÑ ÀÌÈÄ ÀÌ ¾÷°è´Â Å« ±âȸ¸¦ ¾ò¾î Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Àΰ£ À¯ÀüÀÚ¿Í À¯ÀüÀÚ °Ë»çÀÇ ¹üÀ§°¡ ³Ð¾îÁö°í ÀÖ´Â °Í°ú ¸¶Âù°¡Áö·Î ¼öÀǾ÷°è¿¡¼ÀÇ DNA ÇÁ·ÎÆÄÀϸµ ÀýÂ÷µµ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Á¤È®¼º¿¡ °üÇØ¼´Â ¹Ý·Áµ¿¹°À» À§ÇÑ Áý¿¡¼ÀÇ DNA »ùÇøµ °Ë»ç´Â ¹æ´ëÇÑ °¡Ä¡ ÀÖ´Â Á¤º¸·Î ½Å·ÚÇÒ ¼ö ÀÖ´Ù´Â °ÍÀÌ Áõ¸íµÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¸é Embark Veterinary, Inc.´Â ±× ǰÁ¾ ÇÁ·ÎÆÄÀÏ °Ë»çÀÇ Á¤¹Ðµµ´Â 95% ÀÌ»óÀ̶ó°í ÇÕ´Ï´Ù.
¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- µ¿¹° À¯Çüº°·Î ¹Ì±¹¿¡¼ °¾ÆÁö »çÀ°·üÀÌ ³ô±â ¶§¹®¿¡ °³ ºÎ¹®Àº 2024³â¿¡ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- Ÿ¾× DNA °Ë»ç´Â ¹Ý·Áµ¿¹°ÀÇ À¯ÀüÀÚ ±¸¼ºÀ» ¿¹ÃøÇϱâ À§ÇØ ´õ ÀαⰡ ÀÖ°í ³Î¸® ½Ç½ÃµÇ¾ú±â ¶§¹®¿¡ Ÿ¾× »ùÇà À¯Çü ºÎ¹®Àº 2024³â¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- °Ë»ç À¯Çüº°·Î °ßÁ¾ ÇÁ·ÎÆÄÀÏ ºÎ¹®Àº 2024³â 38.07%ÀÇ ÃÖ°í ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ¼¼°èÀÇ ºê¸®´õ´Â ¸ðµç ¼¼´ëÀÇ ÁÖÀÎÀÇ ¿ä±¸¿¡ ¸Â°Ô ¾çÁúÀÇ ÇüÁúÀ» °¡Áø ´õ ³ªÀº °ßÁ¾°ú °í¾çÀÌ Á¾ÀÇ ¹ø½ÄÀ» À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.
- °Ô´Ù°¡ °íǰÁúÀÇ ¸ð»ö, ´«ÀÇ »ö, ü°í, üÁß µîÀÇ ½ÅüÀû Ư¡°ú ÇÔ²² ÁÖÀÎÀº º¸´Ù ¿ì¼öÇÑ °Ç°»óÅÂ¿Í Æ¯Á¤ ÀÛ¾÷¿¡ ÀÖ¾î¼ Àç´ÉÀ» °¡Áø µ¿¹°µµ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù.
- 2024³â¿¡´Â ºÏ¹Ì°¡ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ºÏ¹ÌÀÇ Çù·Â °ü°è¿Í ±â¾÷ Á¦ÈÞ Áõ°¡°¡ ½ÃÀåÀ» Å©°Ô Ȱ¼ºÈÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ º¯¼ö, µ¿Çâ ¹× ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óÀ§ ½ÃÀå Àü¸Á
- °ü·Ã ¹× ºÎ¼ö ½ÃÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ½ÃÀå ±âȸ ºÐ¼®
- ½ÃÀå °úÁ¦ ºÐ¼®
- ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå ºÐ¼® µµ±¸
- Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
- COVID-19 ºÐ¼®
- ÁÖ¿äÁ¾ ¹× ÁÖ¿ä ±¹°¡º° ¹Ý·Áµ¿¹° ÃßÁ¤ °³Ã¼¼ö(2018-2024³â)
- ±ÔÁ¦ ¹× »óȯÀÇ »óȲ
- °¡°Ý ºÐ¼®
- »ç¿ëÀÚÀÇ ½ÃÁ¡ ºÐ¼®
- ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚÀÇ Àα¸Åë°è ÇÁ·ÎÆÄÀÏ ¹× °üÁ¡ ºÐ¼®
- ºê¸®´õÀÇ ½ÃÁ¡À¸·ÎºÎÅÍÀÇ ºÐ¼®
- ¼öÀÇ»çÀÇ ½ÃÁ¡À¸·ÎºÎÅÍÀÇ ºÐ¼®
- COVID-19ÀÇ ¿µÇ⠺м®
Á¦4Àå ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : µ¿¹° À¯Çüº° ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¼¼°è ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
- ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå ±Ô¸ð ¹× µ¿Ç⠺м® : µ¿¹° À¯Çüº°(2018-2030³â)
- °³
- °í¾çÀÌ
- ±âŸ µ¿¹°
Á¦5Àå ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : »ùÇà À¯Çüº° ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¼¼°è ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
- ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå ±Ô¸ð ¹× µ¿Ç⠺м® : »ùÇà À¯Çüº°(2018-2030³â)
- ÇÇ
- Ÿ¾×
- ºÐº¯
- ±âŸ
Á¦6Àå ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : °Ë»ç À¯Çüº° ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¼¼°è ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
- ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå ±Ô¸ð ¹× µ¿Ç⠺м® : °Ë»ç À¯Çüº°(2018-2030³â)
- ǰÁ¾ ÇÁ·ÎÆÄÀÏ
- À¯Àü¼º Áúȯ
- °Ç°°ú À£ºù
Á¦7Àå ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ¼¼°è ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
- ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå ±Ô¸ð ¹× µ¿Ç⠺м® : ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
- ¹Ý·Áµ¿¹° ÁÖÀÎ
- ºê¸®´õ
- ¼öÀÇ»ç
Á¦8Àå ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : Áö¿ªº° ÃßÁ¤ ¹× µ¿Ç⠺м®
- Áö¿ª ´ë½Ãº¸µå
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®(2018-2030³â)
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ½º¿þµ§
- µ§¸¶Å©
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦9Àå °æÀï ±¸µµ
- ½ÃÀå ÁøÃâ ±â¾÷ÀÇ ºÐ·ù
- ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´× ºÐ¼® ¹× È÷Æ® ¸Ê ºÐ¼®
- ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ¿¹Ãø ºÐ¼®(2024³â)
- Àü·« ¸ÅÇÎ
- ÇÕº´ ¹× Àμö
- ÆÄÆ®³Ê½Ê ¹× Çù¾÷
- ±âŸ
- ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Zoetis Inc.(Basepaws Inc.)
- Mars Petcare(Wisdom Panel)
- Orivet Genetic Pet Care Limited
- Embark Veterinary, Inc.
- Dognomics(Clinomics)
- DNA MY DOG(Canadian Dog Group Ltd.)
- Neogen Corporation
- EasyDNA(Genetic Technologies)
- CirclePaw(Prenetics Global Limited)
- Macrogen, Inc.
Á¦10Àå Áß¿äÇÑ Æ÷ÀÎÆ®
AJY
¿µ¹® ¸ñÂ÷
Pet DNA Testing Market Growth & Trends:
The global pet DNA testing market size is estimated to reach USD 718.51 million by 2030, registering a CAGR of 10.16% from 2025 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the industry growth include a rise in consumer genomics, high pet expenditure & pet humanization, increased awareness & sale of pet DNA testing products, and an increase in the number of R&D initiatives. Owing to a significant increase in the pet adoption rate in recent years, families are spending more time and money on their companions. According to the American Pet Products Association (APPA), the U.S. pet industry expenditure reached USD 123.6 billion in 2021 from USD 103.6 billion in 2020, increasing by 19%.
The COVID-19 pandemic resulted in significant growth of the pet industry by setting new trends. Some noteworthy trends were a sudden increase in the adoption of dogs & cats, a rise in pet humanization trends with a large amount of time spent by owners at home, an increase in awareness among people about pet diseases & behavioral changes, and the growth of e-commerce platforms. High household income, changes in financial situations, and remote working were also among the strong factors responsible for increased adoption of new pets during the pandemic. DNA testing has shown several potential benefits for companion animals by providing information that the owner needs to prepare their pets for the future.
Knowing certain genetic hereditary diseases in advance enables owners to start timely treatments, also potentially avoiding costly medication or diagnostic bills later on. Current generations are widely active on social media, enabling them to quickly adapt to new pet trends. This factor is increasing awareness among pet parents regarding pet breed test products, their ease of use, and their enormous applications. People spend heavy amountson various animal products. Their keen interest in understanding pets' age, breed mix, and ancestral relations allow owners to guess their pet's behavioral patterns and start required training. Furthermore, the increased interest of people in the U.S. in certain pet breed categories has increased the requirement for breed testing and its products among professional breeders.
The usage of pet DNA testing and genetic profiling before breeding procedures prevents breeders from producing puppies with a high risk of diseases. Owing to these affirmative factors, awareness and sales of pet DNA testing products are expected to grow in the long run.As the field of genomics is advancing in the veterinary industry, pet genetic test kits are becoming more common. Companies are offering at-home dog & cat DNA testing resources for breeders, pet owners, and veterinarians for over 15 years. Since the introduction of direct-to-consumer genetic test products in 2009 by Mars Petcare, the industry has been significantly growing with considerable opportunities. Similar to the widening scope of human genomics and genetic testing, DNA profiling procedures in veterinary industries are growing. With regard to the accuracy, at-home DNA sampling tests for pets have proven to be reliable with enormous valuable information. For example, Embark Veterinary, Inc. states that its breed profile tests are over 95% accurate.
Pet DNA Testing Market Report Highlights:
- Based on animal type, the dogs segment accounted for the largest revenue share in 2024, due to the high adoption of dogs in the U.S.
- The saliva sample type segment held the largest share in 2024, as saliva DNA tests are more popular and widely performed for predicting the genetic makeup of pets
- On the basis of test type, the breed profile segment held the highest revenue share of 38.07% in 2024.
- Breeders around the world are striving to breed better dog or cat breeds with quality traits for every generation of owners to suit their requirements
- Moreover, along with physical features, such as quality fur color, eye color, height, and weight, owners also look for animals with better health and talents in specific tasks
- North America accounted for the largest revenue share in 2024. The increase in collaboration and corporate partnerships in North America is significantly fueling the market.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Regional Scope
- 1.1.2. Estimates and Forecast Timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis
- 1.6.2. Global Market: CAGR Calculation
- 1.7. Research Scope and Assumptions
- 1.7.1. List of Secondary Sources
- 1.7.2. List of Primary Sources
- 1.7.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Pet DNA Testing Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Rise in consumer genomics
- 3.2.1.2. Growing pet expenditure & pet humanization
- 3.2.1.3. Increasing awareness & sales of pet DNA testing products
- 3.2.1.4. Rising R&D initiatives
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Concerns over accuracy and quality of test results
- 3.2.2.2. Lack of standard regulations
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Pet DNA Testing Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental Landscape
- 3.3.2.5. Legal landscape
- 3.4. Covid-19 Analysis
- 3.5. Estimated Pet Population, 2018-2024, by Key Species & Key Countries
- 3.6. Regulatory & Reimbursement Landscape
- 3.7. Pricing Analysis
- 3.8. User Perspective Analysis
- 3.8.1. Pet Owner Demographic Profile & Perspective Analysis
- 3.8.2. Breeders' Perspective Analysis
- 3.8.3. Veterinarians' Perspective Analysis
- 3.9. COVID-19 Impact Analysis
Chapter 4. Pet DNA Testing Market: Animal Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Pet DNA Testing Market Movement Analysis
- 4.3. Global Pet DNA Testing Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
- 4.4. Dogs
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5. Cats
- 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6. Other Animal
- 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pet DNA Testing Market: Sample Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Pet DNA Testing Market Movement Analysis
- 5.3. Global Pet DNA Testing Market Size & Trend Analysis, by Sample Type, 2018 to 2030 (USD Million)
- 5.4. Blood
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.5. Saliva
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.6. Fecal
- 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pet DNA Testing Market: Test Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Pet DNA Testing Market Movement Analysis
- 6.3. Global Pet DNA Testing Market Size & Trend Analysis, by Test Type, 2018 to 2030 (USD Million)
- 6.4. Breed Profile
- 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5. Genetic Diseases
- 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6. Health and Wellness
- 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pet DNA Testing Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Pet DNA Testing Market Movement Analysis
- 7.3. Global Pet DNA Testing Market Size & Trend Analysis, End Use, 2018 to 2030 (USD Million)
- 7.4. Pet Owners
- 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5. Breeders
- 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6. Veterinarians
- 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Pet DNA Testing Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 North America
- 8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Insights
- 8.3.2.3. U.S. Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Insights
- 8.3.3.3. Canada Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Insights
- 8.3.4.3. Mexico Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Insights
- 8.4.2.3. U.K. Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Insights
- 8.4.3.3. Germany Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Insights
- 8.4.4.3. France Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Insights
- 8.4.5.3. Italy Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Insights
- 8.4.6.3. Spain Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Sweden
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Insights
- 8.4.7.3. Sweden Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Insights
- 8.4.8.3. Denmark Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Competitive Insights
- 8.4.9.3. Norway Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.5.2. China
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Insights
- 8.5.2.3. China Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Japan
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Insights
- 8.5.3.3. Japan Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Insights
- 8.5.4.3. India Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Insights
- 8.5.5.3. South Korea Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Insights
- 8.5.6.3. Australia Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Insights
- 8.5.7.3. Thailand Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Insights
- 8.6.2.3. Brazil Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Insights
- 8.6.3.3. Argentina Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Middle East and Africa
- 8.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Saudi Arabia
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Insights
- 8.7.2.3. Saudi Arabia Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. South Africa
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Insights
- 8.7.3.3. South Africa Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Insights
- 8.7.4.3. UAE Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Insights
- 8.7.5.3. Kuwait Pet DNA Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Company Market Position Analysis/ Heat Map Analysis
- 9.3. Estimated Company Market Share Analysis, 2024
- 9.4. Strategy Mapping
- 9.4.1. Mergers & Acquisitions
- 9.4.2. Partnerships & Collaborations
- 9.4.3. Others
- 9.5. Company Profiles
- 9.5.1. Zoetis Inc. (Basepaws Inc.)
- 9.5.1.1. Participant's Overview
- 9.5.1.2. Financial Performance
- 9.5.1.3. Product Benchmarking
- 9.5.1.4. Strategic Initiatives
- 9.5.2. Mars Petcare (Wisdom Panel)
- 9.5.2.1. Participant's Overview
- 9.5.2.2. Financial Performance
- 9.5.2.3. Product Benchmarking
- 9.5.2.4. Strategic Initiatives
- 9.5.3. Orivet Genetic Pet Care Limited
- 9.5.3.1. Participant's Overview
- 9.5.3.2. Financial Performance
- 9.5.3.3. Product Benchmarking
- 9.5.3.4. Strategic Initiatives
- 9.5.4. Embark Veterinary, Inc.
- 9.5.4.1. Participant's Overview
- 9.5.4.2. Financial Performance
- 9.5.4.3. Product Benchmarking
- 9.5.4.4. Strategic Initiatives
- 9.5.5. Dognomics (Clinomics)
- 9.5.5.1. Participant's Overview
- 9.5.5.2. Financial Performance
- 9.5.5.3. Product Benchmarking
- 9.5.5.4. Strategic Initiatives
- 9.5.6. DNA MY DOG (Canadian Dog Group Ltd.)
- 9.5.6.1. Participant's Overview
- 9.5.6.2. Financial Performance
- 9.5.6.3. Product Benchmarking
- 9.5.6.4. Strategic Initiatives
- 9.5.7. Neogen Corporation
- 9.5.7.1. Participant's Overview
- 9.5.7.2. Financial Performance
- 9.5.7.3. Product Benchmarking
- 9.5.7.4. Strategic Initiatives
- 9.5.8. EasyDNA (Genetic Technologies)
- 9.5.8.1. Participant's Overview
- 9.5.8.2. Financial Performance
- 9.5.8.3. Product Benchmarking
- 9.5.8.4. Strategic Initiatives
- 9.5.9. CirclePaw (Prenetics Global Limited)
- 9.5.9.1. Participant's Overview
- 9.5.9.2. Financial Performance
- 9.5.9.3. Product Benchmarking
- 9.5.9.4. Strategic Initiatives
- 9.5.10. Macrogen, Inc.
- 9.5.10.1. Participant's Overview
- 9.5.10.2. Financial Performance
- 9.5.10.3. Product Benchmarking
- 9.5.10.4. Strategic Initiatives
Chapter 10. Key Takeaways
°ü·ÃÀÚ·á